---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-042546"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2024-10-25T23:59:59+00:00"
generated_at: "2026-05-30T10:09:31.551915+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals issues 33,333 shares under ELOC and converts 200 Series B shares into 93,299 common shares

## Summary
- Sold 33,333 shares at $2.36 each for net proceeds of $78,787 under the $25M ELOC with Platinum Point Capital.
- Converted 200 Series B Preferred shares into 93,299 common shares at $2.358/share, value $220,000.
- Both issuances exempt from registration under Securities Act (Section 4(a)(2)/Rule 506 and Section 3(a)(9)).
- Resale of shares under ELOC and conversion are covered by effective registration statements.

## SEC filing metadata
- accession: 0001493152-24-042546
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2024-10-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/0001493152-24-042546-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315224042546/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-042546
- JSON: https://secwatch.observer/filing/0001493152-24-042546.json
- Plain text: https://secwatch.observer/filing/0001493152-24-042546.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.